Alpha Tau Medical (DRTS) Other Non Operating Income (2023 - 2024)
Alpha Tau Medical's (DRTS) quarterly Other Non Operating Income came in at $8.1 million in Q4 2024, down 24.74% year-on-year from $10.8 million in Q1 2024, and down 24.74% quarter-over-quarter from $10.8 million in Q4 2023.
Alpha Tau Medical (DRTS) Other Non Operating Income (2023 - 2024) Analysis & Trends
Alpha Tau Medical has disclosed Other Non Operating Income across 2 years of filings, most recently posting $8.1 million for Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Alpha Tau Medical | 2,416.70 | -76.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 8.14 Mn |
| Dec 31, 2023 | 10.82 Mn |